blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0759441

EP0759441 - Methods of treating neuropeptide Y-associated conditions [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.06.2000
Database last updated on 24.04.2024
Most recent event   Tooltip02.06.2000Application deemed to be withdrawnpublished on 19.07.2000 [2000/29]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [1997/09]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, Indiana 46285 / US
Inventor(s)01 / Bue-Valleskey, Juliana Maude
2422 E. Northgate Street
Indianapolis, Indiana 46220 / US
02 / Heiman, Mark Louis
5740 Susan Drive East
Indianapolis, Indiana 46250 / US
03 / Stephens, Thomas Wesley
5342 Calder Way, Apartment 510
Indianapolis, Indiana 46226 / US
04 / Tinsley, Frank C.
8218 Woonsocket Court
Indianapolis, Indiana 46256 / US
[1997/09]
Representative(s)Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor Windlesham
Surrey GU20 6PH / GB
[N/P]
Former [1997/09]Tapping, Kenneth George, et al
Lilly Industries Limited European Patent Operations Erl Wood Manor
Windlesham Surrey GU20 6PH / GB
Application number, filing date96304723.826.06.1996
[1997/09]
Priority number, dateUS1995000074030.06.1995         Original published format: US 740
US1995000591027.10.1995         Original published format: US 5910
US1995000075230.06.1995         Original published format: US 752
US1995000591127.10.1995         Original published format: US 5911
[1997/09]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0759441
Date:26.02.1997
Language:EN
[1997/09]
Type: A3 Search report 
No.:EP0759441
Date:30.06.1999
[1999/26]
Search report(s)(Supplementary) European search report - dispatched on:EP18.05.1999
ClassificationIPC:C07K14/47, A61K38/17, // (A61K38/17, 31:00),(A61K38/17, 31:445)
[1997/09]
CPC:
C07K14/4702 (EP,US); A61K38/17 (EP,US); C07D307/20 (EP,US);
C07D333/56 (EP,US)
C-Set:
A61K38/17, A61K2300/00 (US,EP);
A61K38/17, A61K31/34 (US,EP);
A61K38/17, A61K31/40 (US,EP);
A61K38/17, A61K31/44 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/09]
Extension statesAL06.07.1996
LT06.07.1996
LV06.07.1996
SI06.07.1996
TitleGerman:Verfahren zur Behandlung von mit Neuropeptid Y assozierten Zuständen[1997/09]
English:Methods of treating neuropeptide Y-associated conditions[1997/09]
French:Procédés de traitement des pathologies associées aux peptides neuropeptide Y[1997/09]
Examination procedure06.07.1996Examination requested  [1997/09]
01.01.2000Application deemed to be withdrawn, date of legal effect  [2000/29]
11.02.2000Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2000/29]
Request for further processing for:25.03.1997Request for further processing filed
25.03.1997Full payment received (date of receipt of payment)
Request granted
09.07.1997Decision despatched
Fees paidRenewal fee
30.04.1998Renewal fee patent year 03
07.06.1999Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9500161  (UNIV CINCINNATI [US], et al) [A] 1-18* whole document *;
 [PX]WO9605309  (UNIV ROCKEFELLER [US], et al) [PX] 1-13 * claims, esp. claim 28, page 35, line 21 - page 40, line 10, page 75, line 15 - page 78, line 30, examples *;
 [PX]EP0716854  (LILLY CO ELI [US]) [PX] 14-18 * claims, examples *;
 [E]EP0725079  (LILLY CO ELI [US]) [E] 1-13 * Table 1 and claims *;
 [PX]EP0754464  (LILLY CO ELI [US]) [PX] 1-18 * whole document, esp. claims and examples *;
 [PX]WO9702004  (LILLY CO ELI [US], et al) [PX] 1-13 * page 19, lines 28-30, claims, examples *;
 [XY]  - ZHANG, YIYING ET AL, "Positional cloning of the mouse obese gene and its human homolog", NATURE (LONDON) (1994), 372(6505), 425-32 CODEN: NATUAS;ISSN: 0028-0836, (1994), XP002003607 [X] 1-13 * Figures, esp. page 431 * [Y] 14-18

DOI:   http://dx.doi.org/10.1038/372425a0
 [XY]  - MURAKAMI T ET AL, "CLONING OF RAT OBESE CDNA AND ITS EXPRESSION IN OBESE RATS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (19950426), vol. 209, no. 3, pages 944 - 952, XP002003621 [X] 1-13 * whole document, esp. Fig.2 * [Y] 14-18

DOI:   http://dx.doi.org/10.1006/bbrc.1995.1589
 [Y]  - VETTOR R. ET AL., "Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats", CHEMICAL ABSTRACTS, (19950327), vol. 122, no. 13, Database accession no. 152145, XP002097501 [Y] 1-18 * abstract *
 [Y]  - VETTOR R. ET AL., "Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats", DIABETOLOGIA, (1994), vol. 37, no. 12, pages 1202 - 8 [Y] 1-18
 [A]  - CONSIDINE R V ET AL, "EVIDENCE AGAINST EITHER A PREMATURE STOP CODON OR THE ABSENCE OF OBESE GENE MRNA IN HUMAN OBESITY", JOURNAL OF CLINICAL INVESTIGATION, (19950601), vol. 95, no. 6, pages 2986 - 2988, XP000571447 [A] 1-13 * whole document, esp. Fig.1 *

DOI:   http://dx.doi.org/10.1172/JCI118007
 [A]  - EDVINSSON L ET AL, "NEUROPEPTIDE Y IN SYMPATHETIC CO-TRANSMISSION: RECENT ADVANCES IN THE SEARCH FOR NEUROPEPTIDE Y ANTAGONISTS", PHARMACOLOGY AND TOXICOLOGY, (1994), vol. 74, pages 193 - 201, XP002005758 [A] 14-18 * whole document *

DOI:   http://dx.doi.org/10.1111/j.1600-0773.1994.tb01098.x
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.